{
    "startDate": "2019-01-01",
    "endDate": "2019-06-30",
    "year": "2019",
    "quarter": "Q2",
    "symbol": "TROV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents\u2014Beginning of period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 10791270
            },
            {
                "label": "Accounts receivable and unbilled receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 122281
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 906466
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 11820017
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 252053
            },
            {
                "label": "Decrease in operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1660631
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 135262
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 13867963
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 525690
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2352265
            },
            {
                "label": "Current operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 816102
            },
            {
                "label": "Deferred rent, current portion",
                "concept": "DeferredRentCreditCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3694057
            },
            {
                "label": "Balance of derivative financial instruments liability at the beginning of the period",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 18287
            },
            {
                "label": "Non-current operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1307384
            },
            {
                "label": "Deferred rent, net of current portion",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 5019728
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value, 20,000,000 shares authorized; 277,100 designated as Series A Convertible Preferred Stock; 60,600 shares outstanding at June 30, 2019 and December 31, 2018 with liquidation preference of $606,000 at June 30, 2019 and December 31, 2018; 200,000 designated as Series C Convertible Preferred Stock; 0 shares outstanding at June 30, 2019 and December 31, 2018",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 60
            },
            {
                "label": "Common stock, $0.0001 par value, 150,000,000 shares authorized; 5,441,390 and 3,831,880 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 7997
            },
            {
                "label": "Additional Paid-In Capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 210706090
            },
            {
                "label": "Service receivable",
                "concept": "trov:Servicereceivable",
                "unit": "usd",
                "value": 1364234
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -200501678
            },
            {
                "label": "Stockholders' Equity Note [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 8848235
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 13867963
            }
        ],
        "cf": [
            {
                "label": "Numerator: Net loss attributable to common shareholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8030074
            },
            {
                "label": "Loss on disposal of assets",
                "concept": "GainLossOnDispositionOfAssets1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Impairment loss",
                "concept": "RestructuringCostsAndAssetImpairmentCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 87219
            },
            {
                "label": "Award Type [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 348901
            },
            {
                "label": "Gain on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred rent",
                "concept": "IncreaseDecreaseInDeferredCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": 14028
            },
            {
                "label": "Release of clinical trial funding commitment",
                "concept": "trov:Releaseofclinicaltrialfundingcommitmentforservicesreceived",
                "unit": "usd",
                "value": 310766
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 32464
            },
            {
                "label": "Accounts receivable and unbilled receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -45474
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": -163950
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": -309713
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 387046
            },
            {
                "label": "Operating lease liabilities",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -379662
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -6803159
            },
            {
                "label": "Capital expenditures",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 5274
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -5274
            },
            {
                "label": "Proceeds from sales of common stock and warrants, net of expenses of $97,260 and $1,336,123, respectively",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 2902740
            },
            {
                "label": "Proceeds from sales of Series B Convertible Preferred Stock, net of expenses of $497,617",
                "concept": "ProceedsFromIssuanceOfConvertiblePreferredStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Costs related to the clinical trial funding commitment",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": -40000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 3283830
            },
            {
                "label": "Payment upon debt extinguishment",
                "concept": "PaymentsOfDebtExtinguishmentCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Repayments of equipment line of credit",
                "concept": "RepaymentsOfLongTermLinesOfCredit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 6146570
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "NetCashProvidedByUsedInContinuingOperations",
                "unit": "usd",
                "value": -661863
            },
            {
                "label": "Cash paid for taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 800
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "trov:PreferredStockDividendAccrued",
                "unit": "usd",
                "value": 12120
            },
            {
                "label": "Common stock, preferred stock and warrants issued in connection with clinical trial funding commitment",
                "concept": "trov:Commonstockpreferredstockandwarrantsissuedinconnectionwithclinicaltrialfundingcommitment",
                "unit": "usd",
                "value": 1675000
            }
        ],
        "ic": [
            {
                "label": "Revenues [Abstract]",
                "concept": "Revenues",
                "unit": "usd",
                "value": 300243
            },
            {
                "label": "Cost of revenues",
                "concept": "CostOfRevenue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 5478939
            },
            {
                "label": "Selling, general and administrative expense",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 3003026
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Costs and expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 8481965
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -8181722
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 134504
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": 14028
            },
            {
                "label": "Gain on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 3116
            },
            {
                "label": "Numerator: Net loss attributable to common shareholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8030074
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "PreferredStockDividendsIncomeStatementImpact",
                "unit": "usd",
                "value": 12120
            },
            {
                "label": "Numerator: Net loss attributable to common shareholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -8310463
            },
            {
                "label": "Net loss per common share - basic (in USD per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.78
            },
            {
                "label": "Net loss per common share - diluted (in USD per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.78
            },
            {
                "label": "Weighted-average shares used to compute basic loss per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 4667434
            },
            {
                "label": "Weighted-average shares used to compute diluted net loss per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 4667434
            }
        ]
    }
}